Cullinan Oncology Inc
NASDAQ:CGEM

Watchlist Manager
Cullinan Oncology Inc Logo
Cullinan Oncology Inc
NASDAQ:CGEM
Watchlist
Price: 10.26 USD 2.6%
Market Cap: 606.2m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of CGEM.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CGEM Intrinsic Value
Not Available
Base Case Scenario
Compare CGEM to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CGEM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cullinan Oncology Inc

Current Assets 342.2m
Cash & Short-Term Investments 332.6m
Other Current Assets 9.6m
Non-Current Assets 141.9m
Long-Term Investments 140m
PP&E 1.5m
Other Non-Current Assets 361k
Current Liabilities 32.8m
Accounts Payable 1.7m
Accrued Liabilities 29.5m
Other Current Liabilities 1.5m
Efficiency

Free Cash Flow Analysis
Cullinan Oncology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cullinan Oncology Inc

Revenue
0 USD
Operating Expenses
-241.4m USD
Operating Income
-241.4m USD
Other Expenses
24.6m USD
Net Income
-216.8m USD
Fundamental Scores

CGEM Profitability Score
Profitability Due Diligence

Cullinan Oncology Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
hidden
Profitability
Score

Cullinan Oncology Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CGEM Solvency Score
Solvency Due Diligence

Cullinan Oncology Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
High Altman Z-Score
hidden
Solvency
Score

Cullinan Oncology Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CGEM Price Targets Summary
Cullinan Oncology Inc

Wall Street analysts forecast CGEM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CGEM is 32.84 USD with a low forecast of 22.22 USD and a high forecast of 55.65 USD.

Lowest
Price Target
22.22 USD
117% Upside
Average
Price Target
32.84 USD
220% Upside
Highest
Price Target
55.65 USD
442% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cullinan Oncology Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CGEM is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CGEM Insider Trading
Buy and sell transactions by insiders